Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Topotecan in MDS
NCT00003675Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 1999
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in myelodysplastic syndrome (MDS), sponsored by Cancer and Leukemia Group B. Started Mar 1999; status: completed.
02
Drugs
topotecan
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00003675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003675.